4.2 Review

Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and future prospects

Journal

JOURNAL OF PHARMACEUTICAL INVESTIGATION
Volume 51, Issue 4, Pages 377-398

Publisher

SPRINGERNATURE
DOI: 10.1007/s40005-021-00525-z

Keywords

Antimicrobial peptide; Bacterial infection; Nanoparticles; Nanomedicine

Funding

  1. University of Oslo (Oslo University Hospital)

Ask authors/readers for more resources

Nanomedicine-based AMP delivery systems are a recent approach for treating bacterial infections, with advantages such as enhancing AMP stability, controlled release, and targetability. Future studies are needed to address issues like nanoparticle instability, short residence time, and toxicity. Rigorous research on AMP loaded nanoparticle preparation, characterization, in vitro and in vivo antimicrobial effects, and toxicities evaluations are essential.
Background Antimicrobial peptides (AMPs) have gained wide interest as viable alternatives to antibiotics owing to their potent antimicrobial effects and the low propensity of resistance development. However, their physicochemical properties (solubility, charge, hydrophobicity/hydrophilicity), stability issues (proteolytic or enzymatic degradation, aggregation, chemical degradation), and toxicities (interactions with blood components or cellular toxicities) limit their therapeutic applications. Area covered Nanomedicine-based therapeutic delivery is an emerging concept. The AMP loaded nanoparticles have been prepared and investigated for their antimicrobial effects. In this review, we will discuss different nanomedicine-based AMP delivery systems including metallic nanoparticles, lipid nanoparticles, polymeric nanoparticles, and their hybrid systems along with their future prospects for potent antimicrobial efficacy. Expert opinion Nanomedicine-based AMP delivery is a recent approach to the treatment of bacterial infections. The advantageous properties of nanoparticles including the enhancement of AMP stability, controlled release, and targetability make them suitable for the augmentation of AMP activity. Modifications in the nanomedicine-based approach are required to overcome the problems of nanoparticle instability, shorter residence time, and toxicity. Future rigorous studies for both the AMP loaded nanoparticle preparation and characterization, and detailed evaluations of their in vitro and in vivo antimicrobial effects and toxicities, are essential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available